MEC Plus

Developments in Gastric, and Esophageal Tumors
Developments in Gastric, and Esophageal Tumors
Mike Cusnir, MD
Immunotherapy for GU Malignancies and Exciting Developments
Immunotherapy for GU Malignancies and Exciting Developments
Rohit Jain, MD, MPH
Immunotherapy for GYO Malignancies: Is There Still Time for Progress?
Immunotherapy for GYO Malignancies: Is There Still Time for Progress?
Mark Shahin, MD, FACOG, FACS
Establishing IO Management in Gastrointestinal Cancers
Establishing IO Management in Gastrointestinal Cancers
Richard Kim, MD
New Developments in Melanoma Early and Late Stage
New Developments in Melanoma Early and Late Stage
Sanjiv Agarwala, MD
Immunotherapy for Early-Stage Lung Cancer: Adjuvant and Neoadjuvant Approaches
Immunotherapy for Early-Stage Lung Cancer: Adjuvant and Neoadjuvant Approaches
Luis E. Raez, MD, FACP, FCCP
Disparities in Breast Cancer Therapy Outcomes
Disparities in Breast Cancer Therapy Outcomes
Gerardo Colon-Otero, MD
Challenges in Her-2 Breast Cancer
Challenges in Her-2 Breast Cancer
Reshma Mahtani, DO
Guidelines for Hormone Therapy in Breast Cancer
Guidelines for Hormone Therapy in Breast Cancer
Noridza Rivera-Rodriguez, MD
TNBC and Immunotherapy Developments in Breast Cancer
TNBC and Immunotherapy Developments in Breast Cancer
Mariana Chavez-McGregor, MD, MSc
Liquid Biopsy
Liquid Biopsy
Christian Rolfo MD, PhD, MBA, Dr.Hc.
Anticoagulation in the Oncology Patient
Anticoagulation in the Oncology Patient
Pamela B. Dudkiewicz, DNP, ARNP-BC, AOCNP
How Far Have We Gone with Biosimilars?
How Far Have We Gone with Biosimilars?
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Latest Treatments in Triple Negative Breast Cancer
Latest Treatments in Triple Negative Breast Cancer
Hope Rugo, MD, FASCO
Updates on ER+ Breast Cancer
Updates on ER+ Breast Cancer
Joseph A. Sparano, MD, FACP
New Developments in HER2+ Breast
New Developments in HER2+ Breast
Mark Pegram, MD
Immunotherapy in Kidney & Bladder Cancer
Immunotherapy in Kidney & Bladder Cancer
Primo N. Lara Jr.,MD
Toxicities in Immunotherapy
Toxicities in Immunotherapy
Lisa Kottschade, APRN, MSN, CNP
Role of Interventional Radiology in Oncology Care
Role of Interventional Radiology in Oncology Care
Brian F Baigorri, MD, RPVI
Bladder Cancer Updates
Bladder Cancer Updates
Petros Grivas, MD, PhD
Biosimilars Implementation in the United States: Where Opportunities Remain
Biosimilars Implementation in the United States: Where Opportunities Remain
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Advances in the Treatment of CNS Malignancies
Advances in the Treatment of CNS Malignancies
Frances Chow, MD
SCLC Case
SCLC Case
Marie Suga, MD, MPH
Stage IV KRAS Mutant Lung Cancer Case
Stage IV KRAS Mutant Lung Cancer Case
Jonathan W. Riess, MD, MS
EGFR-Mutated Lung Cancers
EGFR-Mutated Lung Cancers
Collin Blakely, MD, PhD